Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases ( <scp>ERN</scp> ‐ <scp>RND</scp> )
The survey data can provide expert guidance that is helpful for healthcare professionals involved in the treatment of behavioural symptoms. Additionally, they offer insights that may inform prioritization and design of therapeutic studies, particularly for existing drugs targeting behavioural disturbances in FTD.
Authors
- Atbin Djamshidian (ORCID: https://orcid.org/0000-0001-7174-6000)
- Tim Van Langenhove
- L. Krajčovičová (ORCID: https://orcid.org/0000-0001-7213-7135)
- Annachiara Cagnin (ORCID: https://orcid.org/0000-0002-0635-4884)
- Marina Boban
- Eloy Rodríguez‐Rodríguez (ORCID: https://orcid.org/0000-0001-7742-677X)
- Johannes Levin (ORCID: https://orcid.org/0000-0001-5092-4306)
- Johanna Krüger (ORCID: https://orcid.org/0000-0003-4346-1133)
- François‐Laurent De Winter (ORCID: https://orcid.org/0000-0001-7753-3575)
- Marion Houot
- Carola Reinhard
- Kathrin Reetz (ORCID: https://orcid.org/0000-0002-9730-9228)
- Robert Rusina (ORCID: https://orcid.org/0000-0002-3864-5459)
- Dario Saracino (ORCID: https://orcid.org/0000-0002-4299-9743)
- Jonathan D. Rohrer (ORCID: https://orcid.org/0000-0002-6155-8417)
- Sabina Capellari (ORCID: https://orcid.org/0000-0003-1631-1439)
- Holm Graeßner (ORCID: https://orcid.org/0000-0001-9803-7183)
- Manuel Menéndez‐González (ORCID: https://orcid.org/0000-0002-5218-0774)
- Rik Vandenberghe
- Lena E. Hjermind
- Casper Wittebrood (ORCID: https://orcid.org/0009-0004-2600-4736)
- Harro Seelar
Institutions
- Centre National de la Recherche Scientifique (FR)
- Universidad de Cantabria (ES)
- University of Padua (IT)
- University Hospital Centre Zagreb (HR)
- Innsbruck Medical University (AT)
- Inserm (FR)
- Universidad de Oviedo (ES)
- University of Zagreb (HR)
- Charles University (CZ)
- Masaryk University (CZ)
- Oulu University Hospital (FI)
- Ghent University Hospital (BE)
- Instituto de Salud Carlos III (ES)
- German Center for Neurodegenerative Diseases (DE)
- Erasmus MC (NL)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- LMU Klinikum (DE)
- Sorbonne Université (FR)
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Instituto de Investigación Marqués de Valdecilla (ES)
- Munich Cluster for Systems Neurology (DE)
- Pitié-Salpêtrière Hospital (FR)
- Istituto delle Scienze Neurologiche di Bologna (IT)
- University Children's Hospital Tübingen (DE)
- UK Dementia Research Institute (GB)
- Hospital Universitario Central de Asturias (ES)
- St. Anne's University Hospital Brno (CZ)
- Thomayer University Hospital (CZ)
- Institut du Cerveau (FR)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Instituto de Investigación Sanitaria del Principado de Asturias (ES)
- University College London (GB)
- University of Tübingen (DE)
- Ludwig-Maximilians-Universität München (DE)
- RWTH Aachen University (DE)
- Erasmus University Rotterdam (NL)
- University of Bologna (IT)
- University of Oulu (FI)
- KU Leuven (BE)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1111/ene.16446
- Citations
- 5
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- Biogen
- Teva Pharmaceutical Industries
- European Commission
- Eisai
- Bayer Vital